Log In
Print
BCIQ
Print
Print this Print this
 

astuprotimut-R (MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI)) (GSK1572932A)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCancer vaccine consisting of recombinant MAGEA3 protein and the AS15 immunostimulant
Molecular Target Melanoma-associated antigen A3 (MAGEA3)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today